Van W. Ellis

Van Ellis has extensive experience in a wide variety of technology-based transactions and corporate matters in the life sciences field. He routinely represents early stage and multinational life sciences companies, including their pharmaceuticals, biologics, diagnostics, medical device, vaccine, and consumer care/OTC divisions. He advises clients on the full range of transactions that arise during the life cycle of a product, from billion dollar global collaborations to daily commercial and operational matters. These transactions include arrangements in the areas of drug discovery, research and development, clinical trials, licensing of development stage and approved products, manufacturing and supply, marketing and co-promotion, technology transfers, strategic alliances and joint ventures. He also counsels clients in connection with initial public offerings and mergers and acquisitions. Prior to joining Morrison & Foerster Van was an Associate General Counsel at the Howard Hughes Medical Institute, where he oversaw the development and implementation of policies governing the conduct of clinical trials, and advised on the formation and launch of a joint venture in South Africa to research co-infection of HIV and tuberculosis.